SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041177
Filing Date
2021-08-05
Accepted
2021-08-05 07:25:44
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-10q_20210630.htm   iXBRL 10-Q 2936885
2 EX-10.1 dyn-ex101_8.htm EX-10.1 891975
3 EX-10.2 dyn-ex102_13.htm EX-10.2 123170
4 EX-31.1 dyn-ex311_6.htm EX-31.1 8504
5 EX-31.2 dyn-ex312_7.htm EX-31.2 8625
6 EX-32.1 dyn-ex321_9.htm EX-32.1 4693
7 EX-32.2 dyn-ex322_10.htm EX-32.2 4613
8 GRAPHIC gy4awevnhdeb000001.jpg GRAPHIC 11154
  Complete submission text file 0001564590-21-041177.txt   9712346

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA dyn-20210630.xsd EX-101.SCH 47043
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyn-20210630_cal.xml EX-101.CAL 46807
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyn-20210630_def.xml EX-101.DEF 112581
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20210630_lab.xml EX-101.LAB 368524
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20210630_pre.xml EX-101.PRE 279271
14 EXTRACTED XBRL INSTANCE DOCUMENT dyn-10q_20210630_htm.xml XML 1571974
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 211146318
SIC: 2834 Pharmaceutical Preparations